300 patients tracked to see if aortic stent holds up over time

NCT ID NCT06094127

First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 20 times

Summary

This study follows 300 people who already received a Zenith Alpha Thoracic Endovascular Graft to treat a thoracic aortic aneurysm or penetrating aortic ulcer. Researchers are checking how well the device works and how safe it is over the long term, especially looking at deaths related to the aortic disease. The goal is to confirm the device's real-world performance and understand outcomes over its expected lifetime.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THORACIC AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU Dijon Bourgogne

    Dijon, 21079, France

  • Centre Hospitalier Regional Universitaire de Lille

    Lille, 59000, France

  • Hopital Marie Lannelongue Groupe Hospitalier Pairs St Joseph

    Le Plessis-Robinson, 92350, France

  • IRCCS Ospedale San Raffaele

    Milan, 20132, Italy

  • IRCCS-University Hospital Sant'Orsolo Polyclinic

    Bologna, 40138, Italy

  • Maastricht University Medical Center

    Maastricht, 6202 AZ, Netherlands

  • Radboud UMC

    Nijmegen, 6500 HB, Netherlands

  • St. Franzikus Hospital Munster

    Münster, 48145, Germany

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, 20246, Germany

  • Universitätsklinikum der LMU München

    München, 81377, Germany

Conditions

Explore the condition pages connected to this study.